Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

231 - 240 of 6604 results found

A Randomized Trial of Nafamostat for Covid-19

Date
Tuesday, February 06, 2024 - 4:00 AM
Description
A Randomized Trial of Nafamostat for Covid-19Nafamostat mesylate is a potent in vitro antiviral that inhibits the host transmembrane protease serine 2 enzyme used by SARS-CoV-2 for cell entry. Morpeth et al report the results of an open-label

Assessing psychometric challenges and fatigue during the COVID-19 pandemic

Date
Monday, February 05, 2024 - 4:00 AM
Description
Environmental hazards and/or pandemics may push humans to use different protective methods to maintain their well-being. This study aimed to identify populations vulnerable to psychometric challenges and fatigue during the Coronavirus Disease (COVID